John M. Klopp
Technik-/Wissenschafts-/F&E-Leiter bei ACER THERAPEUTICS INC.
Aktive Positionen von John M. Klopp
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 | - |
Karriereverlauf von John M. Klopp
Ehemalige bekannte Positionen von John M. Klopp
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.03.2013 | 01.01.2018 |
Ausbildung von John M. Klopp
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Börse
- Insiders
- John M. Klopp
- Erfahrung
